Amherst, NY, United States of America

Austin Miller

This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignee: Health Research, Inc.. Active years: 2018-2019.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Austin Miller. Retrieved from https://idiyas.com/inventor/austin-miller

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 50.0

 

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2018-2019

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations in Prostate Cancer Detection by Austin Miller

Introduction

Austin Miller is an accomplished inventor based in Amherst, NY (US). He has made significant contributions to the field of medical diagnostics, particularly in the detection of prostate cancer. With a total of 2 patents to his name, Miller's work focuses on improving the accuracy and sensitivity of prostate cancer diagnoses.

Latest Patents

Miller's latest patents include a "Kit for immunological detection of TNF-alpha, sTNFR1 and IL-8 in prostate cancer." This innovative method utilizes biomarkers to enhance the diagnosis of various forms of prostate cancer. The process involves testing biological samples for interleukin-8 (IL-8), Tumor necrosis factor alpha (TNF-α), and soluble tumor necrosis factor-α receptor 1 (sTNFR1). Additionally, it may include testing for prostate serum antigen (PSA). The combination of these markers provides tests that are more sensitive and specific than PSA alone, effectively differentiating between benign and malignant prostate diseases, as well as localized and metastatic prostate cancer.

Another significant patent by Miller is "Biomarkers for prostate cancer comprising interleukin-8 (IL-8), tumor necrosis factor alpha and soluble tumor necrosis factor-alpha receptor 1." This patent also emphasizes the use of biomarkers to improve diagnostic methods for prostate cancer, reinforcing the importance of IL-8, TNF-α, and sTNFR1 in enhancing the specificity and sensitivity of PSA-based diagnoses.

Career Highlights

Miller is currently associated with Health Research, Inc., where he continues to innovate in the field of medical research. His work has been pivotal in advancing the understanding and detection of prostate cancer, contributing to better patient outcomes.

Collaborations

Miller collaborates with notable colleagues such as Kailash Chadha and Willie Underwood, who share his commitment to improving cancer diagnostics.

Conclusion

Austin Miller's contributions to prostate cancer detection through his innovative patents highlight the critical role of biomarkers in medical diagnostics. His work not only enhances the accuracy of diagnoses but also paves the way for improved treatment strategies for patients.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…